Pre-IPO PegBio Co., Ltd. - This GLP-1 Biotech Has Gloomy Outlook
We doubt whether PegBio can make profits or bring expected returns to investors based on the pipeline situation/competitive landscape. The market...
PegBio IPO Preview: A Founder-Led Biopharma Player Fighting T2DM and Obesity in China
PegBio, a promising founder-led biotech company, is seeking to tap capital markets in Hong Kong. Their core product for the treatment of T2DM is at...
No more insights